Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE048B01035
Key metrics
- Market Cap
- ₹1,563 Cr
- P/E Ratio
- 35.32
- EPS
- 6.71
- Book Value
- 41.24
- P/B Ratio
- 5.81
- ROE
- 15.6%
- ROCE
- 17.1%
- Debt / Equity
- 0.03
- Net Margin
- 15%
- Revenue Growth
- 6.89%
- Profit Growth
- -22.18%
- Dividend Yield
- 1.04%
- 52W High
- ₹264.50
- 52W Low
- ₹155.00
- Market Cap Band
- small cap
- Face Value
- 2
Ratios computed from the annual results period ending 2026-03-31.
About Jagsonpal Pharmaceuticals Limited
Jagsonpal Pharmaceuticals Limited engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally. It offers pharmaceutical formulations and products in the areas of gynaecology, orthopaedics, dermatology, and paediatrics. The company provides drugs in the form of tablets, softgels, injections, capsules, and syrups. Jagsonpal Pharmaceuticals Limited was incorporated in 1978 and is based in Gurugram, India.
- Headquarters
- Gurugram, India
- Employees
- 1,297
- Promoter Holding
- 76.06%
The full Jagsonpal Pharmaceuticals Limited analysis
Create a free account to open the complete JAGSNPHARM deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.